Bergen, Norway 31 March 2023
The Annual General Meeting ("AGM") of Lifecare AS will be held on 18 April 2023at 10:00 CET. Notice of the AGM is enclosed to this announcement. Documents forthe AGM are available at www.lifecare.attme.dev/events/.
The meeting will be conducted as a combined in-person and digital meeting.Shareholders who wish to participate and vote at the General Meeting must beregistered with a user profile in the meeting portal Orgbrain (www.orgbrain.no).It will be possible to attend the meeting in-person at Lifecare's main office ordigitally through Orgbrain. Further information about participation andregistration appears from the notice.
This is LifecareLifecare AS is a clinical stage medical sensor company developing technology forsensing and monitoring of various body analytes. Lifecare's main focus is tobring the next generation of Continuous Glucose Monitoring systems to market.Lifecare enables osmotic pressure as sensing principle, combined with theability to manipulate Nano-granular Tunnelling Resistive sensors on the sensorbody for read-out of pressure variations. LifecareŽs sensor technology isreferred to as "Sencell" and is suitable for identifying and monitoring theoccurrence of a wide range of analytes and molecules in the human body.______ Further informationJoacim Holter, CEO, Lifecare AS, firstname.lastname@example.org, +47 40 05 90 40
This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act. This stock exchange announcement waspublished by Joacim Holter, CEO at Lifecare AS, on 31 March 2023 at 11:00 CET.